Expression of Gli1 in the hedgehog signaling pathway and breast cancer recurrence

Chinese Journal of Cancer Research

Volumn 24, Issue 4, 2012, Pages 257-258

  Takebe, Naoko ^a,c   Hunsberger, Sally ^a   Yang, Sherry X ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b National Clinical Target Validation Laboratory   (United States)

^c Cancer Therapy Evaluation Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1;

BREAST CANCER; CANCER RECURRENCE; DISEASE SEVERITY; EDITORIAL; HUMAN; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84875462106     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.1007/s11670-012-0260-2     Document Type: Editorial

References (7)

1. Hui CC, Angers S. Gli proteins in development and disease. Annu Rev Cell Dev Biol 2011;27:513-37.
2. Kubo M, Nakamura M, Tasaki A, et al. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res 2004;64:6071-4.
3. Sahebjam S, Siu LL, Razak AA. The utility of hedgehog signaling pathway inhibition for cancer. Oncologist 2012;17:1090-9.
4. Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009;361:1164-72.
5. Rudin CM, Hann CL, Laterra J, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009;361:1173-8.
6. Takebe N, Harris PJ, Warren RQ, et al. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol 2011;8:97-106.
7. Li YH, Gao HF, Wang Y, et al. Overexpression of Gli1 in cancer interstitial tissues predicts early relapse after radical operation of breast cancer. Chin J Cancer Res 2012;24:263-74.